Ribozyme Product definition

Ribozyme Product or "Product" means a substance that (i) is or is intended to be sold commercially, and (ii) contains a Ribozyme as an active therapeutic or diagnostic (subject to Article 5) for use in the Field.
Ribozyme Product means any substances in the Field that (i) are sold commercially, (ii) contain Exogenous or Endogenous Ribozyme, (iii) were researched pursuant to the Research Plan, (iv) target a Schering Sequence Designated pursuant to Section 5.1, and (v) for which a First Milestone Payment was made pursuant to Section 8.2.
Ribozyme Product means any substance that (i) is or is intended to be ---------------- developed and sold commercially for administration to humans or animals or plants or for therapeutic or diagnostic use and (ii) contains a Ribozyme.

Examples of Ribozyme Product in a sentence

  • If RPI becomes subject to a voluntary or involuntary bankruptcy not discharged within one hundred and eighty (180) days after commencement, RPI will use its best efforts to transfer its interests in assets related to the development and commercialization of a Ribozyme Product, including the employment contracts (if any) with the scientists involved in the Research Collaboration to LILLY.

  • Any member club whose dues fall more than 90 days in arrears and/or who fail representation at three successive meetings of this association, without good reason, may be dropped from this association membership after notification in writing.

  • RPI will assure compliance with regulatory commitments and will correct any deficiencies prior to manufacturing of any Ribozyme Product.

  • As soon as practicable following product launch of a Ribozyme Product, the parties shall meet to review whether it is appropriate to continue the collaboration under the day to day management of the JDT, or whether the objectives of the JDT have been substantially achieved and it is appropriate to disband or reorganize the JDT.

  • Each Party shall promptly notify the other if it receives notice that activities involving the Research Collaboration or the development or commercialization of Ribozyme Product allegedly infringe a Third Party's proprietary rights.

  • LILLY shall have the right to audit and approve all subcontractors selected by RPI to manufacture Ribozyme Product or bulk products as provided and in addition to Section 7.3. LILLY quality assurance shall have the right to audit all manufacturing facilities for Ribozyme Product for clinical studies and commercial sale.

  • LILLY shall pay RPI Royalties on the Net Sales of each Ribozyme Product for the Royalty Term according to the following schedule ("Base Royalties").

  • RPI will promptly notify LILLY of any regulatory inspections and inquiry/communications which involve Ribozyme Product and give LILLY an opportunity to assist RPI in responding to any such inquires.

  • The Parties agree to cooperate in taking commercially reasonable legal actions to protect the commercial interests of the Parties in a Ribozyme Product against infringement by Third Parties.

  • LILLY shall be responsible for determining all regulatory responsibilities for the preparation and filing of all Drug Approval Applications in the name of LILLY and all activities necessary for such Drug Approval Applications including but not limited to the manufacture, marketing and sale of any Ribozyme Product.


More Definitions of Ribozyme Product

Ribozyme Product means any substance that (i) is or is intended to be sold commercially, (ii) contains a Ribozyme, and (iii) was developed against a Validated Target.
Ribozyme Product means a ribozyme product directed toward a Feasibility Study Target or directed toward a Target, for therapeutic or prophylactic or diagnostic use in humans or animals which is developed by a party pursuant to this Agreement.
Ribozyme Product or "PRODUCT" means a substance that (i) is or is intended to be sold commercially, and (ii) contains a Ribozyme as an active therapeutic or diagnostic (subject to Article 5) for use in the Field.

Related to Ribozyme Product

  • Hemp product means the same as that term is defined in § 3.2-4112.

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Licensed Product means any pharmaceutical product containing a Licensed Compound (alone or with other active ingredients), in all forms, presentations, formulations and dosage forms.

  • Collaboration Product means any pharmaceutical product in finished form that contains a Collaboration Compound, either as the sole active ingredient or in combination with one or more other active ingredients, and all present and future formulations, dosages and dosage forms thereof.

  • Non-Microsoft Product means any third-party-branded software, data, service, website or product, unless incorporated by Microsoft in a Product.

  • Nicotine product means a product that contains nicotine and is not any of the following:

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.

  • Licensed Compound means [***].

  • Drug Product means a specific drug in dosage form from a known source of manufacture, whether

  • Generic Product means a product which (a) contains as its active pharmaceutical ingredient a compound that is (or is substantially the same as) the Licensed Compound, and (b) has been placed on the market pursuant to a validly granted marketing authorization.

  • Existing Product means any formulation of the same product category and form sold, supplied, manufactured, or offered for sale in California prior to the following dates, or any subsequently introduced identical formulation:

  • Hemp products means all products made from industrial hemp,

  • medicinal product means any substance or combination of substances presented for treating or preventing disease in human beings or animals and any substance or combination of substances which may be administered to human beings or animals with a view to making a medical diagnosis or to restoring, correcting or modifying physiological functions in humans or in animals;

  • Licensed Products means tangible materials which, in the course of manufacture, use, sale, or importation, would be within the scope of one or more claims of the Licensed Patent Rights that have not been held unpatentable, invalid or unenforceable by an unappealed or unappealable judgment of a court of competent jurisdiction.

  • Licensed Field means all fields of use.

  • Final Product means a product that is not used in producing other products and is built and intended for use outdoors, provided the final product has not deteriorated or has otherwise become a potential source of contaminants.

  • New Products means any product which is not an Enhanced Product or Existing Product but which is substantially similar to an of this Agreement, "New Product" or "New Products" shall mean any product which is not an Enhanced Product or 2 Existing Product but which is substantially similar to an Existing Product with respect to design and function and possesses reasonable performance improvements. If Company desires to purchase an Enhanced or New Product(s) from Supplier, Company shall so notify Supplier and provide Supplier the opportunity to manufacture such Enhanced or New Product(s), subject to the following conditions and procedures.

  • Licensed Compounds means any EZH2 Compound(s) that is:

  • Licensed producer means a person or entity licensed to produce medical cannabis.

  • Bundled Product means Product sold together with any other product(s) or service(s) at a single unit price, whether packaged together or separately, and which other product(s) or service(s) have material independent value from Product itself.

  • Competing Product means [***].

  • End product means those articles, materials, and supplies to be acquired under the contract for public use.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).